Company profile
Ability Biotherapeutics
From depletion to engagement: building precision therapies to modulate immune cells
- Industry
- Biotechnology Research
- Employees
- 31
- Headquarters
- Montreal, Quebec
- Founded
- 2023
- LinkedIn followers
- 3,839
- Office locations
- 2
Ability Biotherapeutics company summary
Ability Biotherapeutics is a company in the Biotechnology Research industry, headquartered in Montreal, Quebec, founded in 2023. On LinkedIn the company has around 31 employees and 3,839 followers. The company lists 2 office locations. Its listed specialties include biotherapeutics, AI/ML, antibodies, autoimmune, inflammation.
What technology does Ability Biotherapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Ability Biotherapeutics
We are a biotechnology company engineering and developing innovative, highly-selective, immune cell modulating biotherapeutics to address unmet medical needs in patients with inflammatory diseases and cancer. Our proprietary AbiLeap™ discovery engine combines massively parallel, continuously learning artificial intelligence (AI) with an extensive proprietary database of therapeutic antibody sequences and antigen-antibody interactions to generate fully-human antibodies with exquisite selectivity and developability. Moreover, AbiLeap™ can generate novel antibodies with particular functions such as dual specificity or pH- or metabolite-sensing without the use of masking. Using this discovery engine, Ability is developing several monospecific and bispecific antibody candidates with selectivity for specific immune cell subpopulations producing novel therapeutics with potentially greatly enhanced safety and efficacy. The lead program is a first-in-class immune cell depleter for inflammatory skin diseases, and subsequent programs include pH-sensing T cell engagers for cancer.
Specialties
Where is Ability Biotherapeutics located?
Ability Biotherapeutics lists 2 office locations.
Compare companies similar to Ability Biotherapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Ability Biotherapeutics ability.bio | Biotechnology Research | 31 | 2023 | Montreal, Quebec |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Ability Biotherapeutics
What does Ability Biotherapeutics do?
We are a biotechnology company engineering and developing innovative, highly-selective, immune cell modulating biotherapeutics to address unmet medical needs in patients with inflammatory diseases and cancer. Our proprietary AbiLeap™ discovery engine combines massively parallel, continuously learning artificial intelligence (AI) with an extensive proprietary database of therapeutic antibody sequences and antigen-antibody interactions to generate fully-human antibodies with exquisite selectivity and developability. Moreover, AbiLeap™ can generate novel antibodies with particular functions such as dual specificity or pH- or metabolite-sensing without the use of masking. Using this discovery engine, Ability is developing several monospecific and bispecific antibody candidates with selectivity for specific immune cell subpopulations producing novel therapeutics with potentially greatly enhanced safety and efficacy. The lead program is a first-in-class immune cell depleter for inflammatory skin diseases, and subsequent programs include pH-sensing T cell engagers for cancer.
How many employees does Ability Biotherapeutics have?
Ability Biotherapeutics has around 31 employees on LinkedIn.
Where is Ability Biotherapeutics headquartered?
Ability Biotherapeutics is headquartered in Montreal, Quebec.
Where does Ability Biotherapeutics have offices?
Ability Biotherapeutics lists 2 office locations, including Montreal, Quebec H3B 2E3, CA; Montreal, Quebec H4S 1Z9, CA.
When was Ability Biotherapeutics founded?
Ability Biotherapeutics was founded in 2023.
Build a lead list from companies like Ability Biotherapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.